Evidence-Based Complementary and Alternative Medicine

Natural Product Acting as Epigenetic Modulating Agents


Publishing date
01 Sep 2022
Status
Published
Submission deadline
29 Apr 2022

Lead Editor

1Case Western Reserve University, Cleveland, USA

2Nanjing University of Chinese Medicine, Nanjing, China

3Nankai University, Tianjin, China


Natural Product Acting as Epigenetic Modulating Agents

Description

In every cell, some specific genes are activated and some genes are suppressed, forming multiple gene expression patterns. In the process of epigenetic regulation, DNA sequence does not change, but gene expression can be genetically altered. Epigenetic changes include DNA methylation, histone modification and noncoding RNA action, genomic imprinting, maternal influence, gene silencing, nucleolar dominance, dormant transposon activation, etc. Fundamentally, epigenetic phenomena are the result of changes in genetic material in living cells caused by environmental factors. Epigenetic changes are caused by interactions between environmental factors and intracellular genetic material. The effect is achieved by regulating gene expression and controlling biological phenotypes. It is precisely because of the importance of epigenetic modifications in maintaining the internal environment and function of various organ systems that epigenetic abnormalities cause disease. This has become the focus of drug and treatment design.

Unlike diseases caused by changes in DNA sequences, many epigenetic changes are reversible. By means of epigenetic modulators, we can change the epigenetic inheritance of abnormal cells to achieve the purpose of treating diseases. Natural products have documented large structural diversity with unique and complex scaffolds with promising activity and selectivity profile for epigenetic targets. Traditional Chinese medicine can be used as an epigenetic regulator to achieve anti-inflammatory, antioxidant, tumor metastasis and recurrence prevention, improve tumor quality of life, and prolong survival time. Microorganisms can also regulate the physiological functions of the host during infection, and epigenetic regulation is an important regulation mode. Epigenetic regulation plays an important role in the host immune responses induced by microorganisms. Clarifying the mechanism of microbial epigenetic regulation on the host is conducive to the development of clinical targeted therapies, strengthening the clinical application of epigenetic modulators, and providing new strategies for the prevention and treatment of related diseases. Strong antioxidants such as polyphenols in fruits, green tea, curcumin, and soy isoflavones can obtain anticancer activity by regulating the patient's epigenome, thereby inhibiting proto-oncogenes or activating tumor suppressors.

This Special Issue welcomes original research and reviews which focus on this topic.

Potential topics include but are not limited to the following:

  • Traditional Chinese medicines as epigenetic modulating agents
  • Microorganisms and their metabolites as epigenetic modulating agents
  • Regulation of epigenetic regulation by animal or plant-derived components
  • Implications of compounds of natural origin in disease-associated epigenetic mechanisms
  • Epigenetics and network pharmacology associated with treatment with natural remedies
  • Repurposing of natural products with epigenetic functions through an integrated –omics analysis

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9878327
  • - Retraction

Retracted: SERPINE1 Gene Is a Reliable Molecular Marker for the Early Diagnosis of Aortic Dissection

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9890380
  • - Retraction

Retracted: MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9838532
  • - Retraction

Retracted: Application of Different Doses of Tranexamic Acid Plus Traditional Chinese Medicine in Hip Arthroplasty in Patients with Diabetes and Its Influence on Intraoperative Blood Loss and Postoperative Drainage

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9839703
  • - Retraction

Retracted: Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9821412
  • - Retraction

Retracted: Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9826305
  • - Retraction

Retracted: Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9839030
  • - Retraction

Retracted: Clinical Efficacy of Budesonide/Glycopyrronium Bromide/Formoterol in the Treatment of Patients with Acute Respiratory Distress Syndrome and Its Effect on Inflammatory Factors

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9827529
  • - Retraction

Retracted: KGF-2 Protects against Lung Ischemia-Reperfusion Injury by Inhibiting Inflammation-Induced Damage to Endothelial Barrier Function

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9854016
  • - Retraction

Retracted: The Relationship between VEGF-C, TAM, and Lymph Node Metastasis in Oral Cancer

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9875013
  • - Retraction

Retracted: The Effect of TLR9, MyD88, and NF-κB p65 in Systemic Lupus Erythematosus

Evidence-Based Complementary and Alternative Medicine
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.